133 related articles for article (PubMed ID: 38834932)
21. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
22. Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience.
Gupta T; Agarwal JP; Ghosh-Laskar S; Parikh PM; D'Cruz AK; Dinshaw KA
Head Neck Oncol; 2009 Jun; 1():17. PubMed ID: 19527507
[TBL] [Abstract][Full Text] [Related]
23. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival.
Slotman GJ; Doolittle CH; Glicksman AS
Cancer; 1992 Jun; 69(11):2736-43. PubMed ID: 1571903
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
[TBL] [Abstract][Full Text] [Related]
25. Nonnasopharyngeal lymphoepithelioma of the head and neck.
Dubey P; Ha CS; Ang KK; El-Naggar AK; Knapp C; Byers RM; Morrison WH
Cancer; 1998 Apr; 82(8):1556-62. PubMed ID: 9554534
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
Salama JK; Vokes EE; Chmura SJ; Milano MT; Kao J; Stenson KM; Witt ME; Haraf DJ
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):382-91. PubMed ID: 16213104
[TBL] [Abstract][Full Text] [Related]
27. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy for stage II nasopharyngeal carcinoma.
Chen J; Liu T; Sun Q; Jin T
Medicine (Baltimore); 2020 Jul; 99(29):e20443. PubMed ID: 32702809
[TBL] [Abstract][Full Text] [Related]
29. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
30. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype.
Rosenthal DI; Barker JL; El-Naggar AK; Glisson BS; Kies MS; Diaz EM; Clayman GL; Demonte F; Selek U; Morrison WH; Ang KK; Chao KS; Garden AS
Cancer; 2004 Dec; 101(11):2567-73. PubMed ID: 15517582
[TBL] [Abstract][Full Text] [Related]
31. Impact of obesity on outcomes for patients with head and neck cancer.
Hicks DF; Bakst R; Doucette J; Kann BH; Miles B; Genden E; Misiukiewicz K; Posner M; Gupta V
Oral Oncol; 2018 Aug; 83():11-17. PubMed ID: 30098765
[TBL] [Abstract][Full Text] [Related]
32. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
[TBL] [Abstract][Full Text] [Related]
33. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes of patients with esthesioneuroblastomas: A cohort from a single institution.
Yin ZZ; Gao L; Luo JW; Yi JL; Huang XD; Qu Y; Wang K; Zhang SP; Xiao JP; Xu GZ; Li YX
Oral Oncol; 2016 Feb; 53():48-53. PubMed ID: 26712253
[TBL] [Abstract][Full Text] [Related]
35. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
Garden AS; Asper JA; Morrison WH; Schechter NR; Glisson BS; Kies MS; Myers JN; Ang KK
Cancer; 2004 Mar; 100(6):1171-8. PubMed ID: 15022283
[TBL] [Abstract][Full Text] [Related]
36. Impact of radiographic findings on for prognosis skin cancer with perineural invasion.
Balamucki CJ; DeJesus R; Galloway TJ; Mancuso AA; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM
Am J Clin Oncol; 2015 Jun; 38(3):248-51. PubMed ID: 23648439
[TBL] [Abstract][Full Text] [Related]
37. Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment.
Caudell JJ; Sawrie SM; Spencer SA; Desmond RA; Carroll WR; Peters GE; Nabell LM; Meredith RF; Bonner JA
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):676-81. PubMed ID: 18355979
[TBL] [Abstract][Full Text] [Related]
38. Loco-regional failures in head and neck cancer: can they be effectively salvaged by nonsurgical therapeutic modalities?
Datta NR; Nagar YS; Singh S; Naryan L
Int J Clin Oncol; 2003 Feb; 8(1):31-9. PubMed ID: 12601540
[TBL] [Abstract][Full Text] [Related]
39. Intensity-Modulated Radiotherapy-Based Reirradiation for Head and Neck Cancer: A Multi-institutional Study by Korean Radiation Oncology Group (KROG 1707).
Lee J; Kim TH; Kim YS; Kim M; Park JW; Kim SH; Kim HJ; Lee CG
Cancer Res Treat; 2020 Oct; 52(4):1031-1040. PubMed ID: 32632081
[TBL] [Abstract][Full Text] [Related]
40. Tolerability, toxicity, and temporal implications of transoral robotic surgery (TORS) on adjuvant radiation therapy in carcinoma of the head and neck.
Carpenter TJ; Kann B; Buckstein MH; Ko EC; Bakst RL; Misiukiewicz KJ; Posner MR; Genden EM; Gupta V
Ann Otol Rhinol Laryngol; 2014 Nov; 123(11):791-7. PubMed ID: 24847162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
